Offstream
news

---

Changes

1. Morocco begins a COVID-19 vaccination program for children aged 12 to 17 years old in effort to ensure their return to schools.
   2021-09-01 13:06:40 (First version)
2. Morocco begins a COVID-19 vaccination program for children aged 12 to 17 years old in an effort to ensure their return to schools.
   (Current version)

---

Related

Morocco lifts its nationwide nightly curfew from 11 p.m. to 5 a.m., which was implemented in order to reduce the spread of COVID-19, due to an improved epidemiological situation in the country.
2021-11-10

Pakistan surpasses one million daily COVID-19 vaccination doses for the first time after the government warned that it may ban unvaccinated people from entering some public places and using some forms of transportation.
2021-08-3

Belgian federal and regional health ministers agree to open vaccination for teenagers aged 16 to 17 years old using Pfizer–BioNTech COVID-19 vaccine. The programme will begin once the vaccination of adults has been completed.
2021-06-5

Poland reopens bars, restaurants, and other establishments for outdoor usage for the first time in seven months and relaxes its mask requirement as the number of COVID-19 cases declines and the number of vaccinations increases.
2021-05-15

Denmark becomes the first country to exclude the Johnson & Johnson COVID-19 vaccine from its vaccination programme over a potential link to a rare but serious form of thrombosis.
2021-05-3

Morocco receives half a million doses of the Sinopharm vaccine.
2021-01-27

The number of daily confirmed cases in Morocco surges by a record 5,836 cases, bringing the nationwide total to 252,185.
2020-11-7

Morocco reports 5,745 new infections and 82 deaths in the past 24 hours, the highest single-day record of both cases and deaths since the pandemic began, bringing the nationwide totals to 235,310 cases and 3,982 deaths.
2020-11-4

Sinopharm began Phase III trials in Peru starting with two dozen people, with the goal to vaccinate 6,000 people between the ages of 18 and 75. So far, Sinopharm has given 30,000 doses to volunteers and another 10,000 participants have received double doses in Bahrain and the United Arab Emirates, with additional trials planned for Morocco and Argentina.
2020-09-10

The first death in Morocco is reported, an 89-year-old woman with pre-existing health conditions.
2020-03-10